Report Overview
Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.
The global Nucleic Acid Based Gene Therapy market size was estimated at USD 4542 million in 2023 and is projected to reach USD 10622.49 million by 2032, exhibiting a CAGR of 9.90% during the forecast period.
North America Nucleic Acid Based Gene Therapy market size was estimated at USD 1392.90 million in 2023, at a CAGR of 8.49% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Nucleic Acid Based Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nucleic Acid Based Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nucleic Acid Based Gene Therapy market in any manner.
Global Nucleic Acid Based Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Wave Life Sciences
Imugene
Sarepta Therapeutics
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Moderna
BioNTech
Nutcracker Therapeutics
Deep Genomics
Sirnaomics
Laronde
Abogen Biosciences
Market Segmentation (by Type)
Anti-Sence and Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Others
Market Segmentation (by Application)
Hospitals and Clinics
Academic and Research Institutes
Others
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Nucleic Acid Based Gene Therapy Market
� Overview of the regional outlook of the Nucleic Acid Based Gene Therapy Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid Based Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nucleic Acid Based Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nucleic Acid Based Gene Therapy
1.2 Key Market Segments
1.2.1 Nucleic Acid Based Gene Therapy Segment by Type
1.2.2 Nucleic Acid Based Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nucleic Acid Based Gene Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Nucleic Acid Based Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Nucleic Acid Based Gene Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nucleic Acid Based Gene Therapy Market Competitive Landscape
3.1 Global Nucleic Acid Based Gene Therapy Sales by Manufacturers (2019-2025)
3.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Manufacturers (2019-2025)
3.3 Nucleic Acid Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nucleic Acid Based Gene Therapy Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Nucleic Acid Based Gene Therapy Sales Sites, Area Served, Product Type
3.6 Nucleic Acid Based Gene Therapy Market Competitive Situation and Trends
3.6.1 Nucleic Acid Based Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nucleic Acid Based Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nucleic Acid Based Gene Therapy Industry Chain Analysis
4.1 Nucleic Acid Based Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nucleic Acid Based Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nucleic Acid Based Gene Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid Based Gene Therapy Sales Market Share by Type (2019-2025)
6.3 Global Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2019-2025)
6.4 Global Nucleic Acid Based Gene Therapy Price by Type (2019-2025)
7 Nucleic Acid Based Gene Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid Based Gene Therapy Market Sales by Application (2019-2025)
7.3 Global Nucleic Acid Based Gene Therapy Market Size (M USD) by Application (2019-2025)
7.4 Global Nucleic Acid Based Gene Therapy Sales Growth Rate by Application (2019-2025)
8 Nucleic Acid Based Gene Therapy Market Consumption by Region
8.1 Global Nucleic Acid Based Gene Therapy Sales by Region
8.1.1 Global Nucleic Acid Based Gene Therapy Sales by Region
8.1.2 Global Nucleic Acid Based Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Nucleic Acid Based Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nucleic Acid Based Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nucleic Acid Based Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nucleic Acid Based Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nucleic Acid Based Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Nucleic Acid Based Gene Therapy Market Production by Region
9.1 Global Production of Nucleic Acid Based Gene Therapy by Region (2019-2025)
9.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Region (2019-2025)
9.3 Global Nucleic Acid Based Gene Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Nucleic Acid Based Gene Therapy Production
9.4.1 North America Nucleic Acid Based Gene Therapy Production Growth Rate (2019-2025)
9.4.2 North America Nucleic Acid Based Gene Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Nucleic Acid Based Gene Therapy Production
9.5.1 Europe Nucleic Acid Based Gene Therapy Production Growth Rate (2019-2025)
9.5.2 Europe Nucleic Acid Based Gene Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Nucleic Acid Based Gene Therapy Production (2019-2025)
9.6.1 Japan Nucleic Acid Based Gene Therapy Production Growth Rate (2019-2025)
9.6.2 Japan Nucleic Acid Based Gene Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Nucleic Acid Based Gene Therapy Production (2019-2025)
9.7.1 China Nucleic Acid Based Gene Therapy Production Growth Rate (2019-2025)
9.7.2 China Nucleic Acid Based Gene Therapy Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Wave Life Sciences
10.1.1 Wave Life Sciences Nucleic Acid Based Gene Therapy Basic Information
10.1.2 Wave Life Sciences Nucleic Acid Based Gene Therapy Product Overview
10.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Product Market Performance
10.1.4 Wave Life Sciences Business Overview
10.1.5 Wave Life Sciences Nucleic Acid Based Gene Therapy SWOT Analysis
10.1.6 Wave Life Sciences Recent Developments
10.2 Imugene
10.2.1 Imugene Nucleic Acid Based Gene Therapy Basic Information
10.2.2 Imugene Nucleic Acid Based Gene Therapy Product Overview
10.2.3 Imugene Nucleic Acid Based Gene Therapy Product Market Performance
10.2.4 Imugene Business Overview
10.2.5 Imugene Nucleic Acid Based Gene Therapy SWOT Analysis
10.2.6 Imugene Recent Developments
10.3 Sarepta Therapeutics
10.3.1 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Basic Information
10.3.2 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Overview
10.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Market Performance
10.3.4 Sarepta Therapeutics Nucleic Acid Based Gene Therapy SWOT Analysis
10.3.5 Sarepta Therapeutics Business Overview
10.3.6 Sarepta Therapeutics Recent Developments
10.4 Alnylam Pharmaceuticals
10.4.1 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Basic Information
10.4.2 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
10.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Market Performance
10.4.4 Alnylam Pharmaceuticals Business Overview
10.4.5 Alnylam Pharmaceuticals Recent Developments
10.5 Ionis Pharmaceuticals
10.5.1 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Basic Information
10.5.2 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
10.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Market Performance
10.5.4 Ionis Pharmaceuticals Business Overview
10.5.5 Ionis Pharmaceuticals Recent Developments
10.6 Moderna
10.6.1 Moderna Nucleic Acid Based Gene Therapy Basic Information
10.6.2 Moderna Nucleic Acid Based Gene Therapy Product Overview
10.6.3 Moderna Nucleic Acid Based Gene Therapy Product Market Performance
10.6.4 Moderna Business Overview
10.6.5 Moderna Recent Developments
10.7 BioNTech
10.7.1 BioNTech Nucleic Acid Based Gene Therapy Basic Information
10.7.2 BioNTech Nucleic Acid Based Gene Therapy Product Overview
10.7.3 BioNTech Nucleic Acid Based Gene Therapy Product Market Performance
10.7.4 BioNTech Business Overview
10.7.5 BioNTech Recent Developments
10.8 Nutcracker Therapeutics
10.8.1 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Basic Information
10.8.2 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Overview
10.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Market Performance
10.8.4 Nutcracker Therapeutics Business Overview
10.8.5 Nutcracker Therapeutics Recent Developments
10.9 Deep Genomics
10.9.1 Deep Genomics Nucleic Acid Based Gene Therapy Basic Information
10.9.2 Deep Genomics Nucleic Acid Based Gene Therapy Product Overview
10.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Product Market Performance
10.9.4 Deep Genomics Business Overview
10.9.5 Deep Genomics Recent Developments
10.10 Sirnaomics
10.10.1 Sirnaomics Nucleic Acid Based Gene Therapy Basic Information
10.10.2 Sirnaomics Nucleic Acid Based Gene Therapy Product Overview
10.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Product Market Performance
10.10.4 Sirnaomics Business Overview
10.10.5 Sirnaomics Recent Developments
10.11 Laronde
10.11.1 Laronde Nucleic Acid Based Gene Therapy Basic Information
10.11.2 Laronde Nucleic Acid Based Gene Therapy Product Overview
10.11.3 Laronde Nucleic Acid Based Gene Therapy Product Market Performance
10.11.4 Laronde Business Overview
10.11.5 Laronde Recent Developments
10.12 Abogen Biosciences
10.12.1 Abogen Biosciences Nucleic Acid Based Gene Therapy Basic Information
10.12.2 Abogen Biosciences Nucleic Acid Based Gene Therapy Product Overview
10.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Product Market Performance
10.12.4 Abogen Biosciences Business Overview
10.12.5 Abogen Biosciences Recent Developments
11 Nucleic Acid Based Gene Therapy Market Forecast by Region
11.1 Global Nucleic Acid Based Gene Therapy Market Size Forecast
11.2 Global Nucleic Acid Based Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nucleic Acid Based Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Nucleic Acid Based Gene Therapy Market Size Forecast by Region
11.2.4 South America Nucleic Acid Based Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Nucleic Acid Based Gene Therapy by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Nucleic Acid Based Gene Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Nucleic Acid Based Gene Therapy by Type (2025-2032)
12.1.2 Global Nucleic Acid Based Gene Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Nucleic Acid Based Gene Therapy by Type (2025-2032)
12.2 Global Nucleic Acid Based Gene Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Nucleic Acid Based Gene Therapy Sales (K MT) Forecast by Application
12.2.2 Global Nucleic Acid Based Gene Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nucleic Acid Based Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Nucleic Acid Based Gene Therapy Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Nucleic Acid Based Gene Therapy Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Nucleic Acid Based Gene Therapy Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Nucleic Acid Based Gene Therapy Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Based Gene Therapy as of 2022)
Table 10. Global Market Nucleic Acid Based Gene Therapy Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Nucleic Acid Based Gene Therapy Sales Sites and Area Served
Table 12. Manufacturers Nucleic Acid Based Gene Therapy Product Type
Table 13. Global Nucleic Acid Based Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nucleic Acid Based Gene Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nucleic Acid Based Gene Therapy Market Challenges
Table 22. Global Nucleic Acid Based Gene Therapy Sales by Type (K MT)
Table 23. Global Nucleic Acid Based Gene Therapy Market Size by Type (M USD)
Table 24. Global Nucleic Acid Based Gene Therapy Sales (K MT) by Type (2019-2025)
Table 25. Global Nucleic Acid Based Gene Therapy Sales Market Share by Type (2019-2025)
Table 26. Global Nucleic Acid Based Gene Therapy Market Size (M USD) by Type (2019-2025)
Table 27. Global Nucleic Acid Based Gene Therapy Market Size Share by Type (2019-2025)
Table 28. Global Nucleic Acid Based Gene Therapy Price (USD/MT) by Type (2019-2025)
Table 29. Global Nucleic Acid Based Gene Therapy Sales (K MT) by Application
Table 30. Global Nucleic Acid Based Gene Therapy Market Size by Application
Table 31. Global Nucleic Acid Based Gene Therapy Sales by Application (2019-2025) & (K MT)
Table 32. Global Nucleic Acid Based Gene Therapy Sales Market Share by Application (2019-2025)
Table 33. Global Nucleic Acid Based Gene Therapy Sales by Application (2019-2025) & (M USD)
Table 34. Global Nucleic Acid Based Gene Therapy Market Share by Application (2019-2025)
Table 35. Global Nucleic Acid Based Gene Therapy Sales Growth Rate by Application (2019-2025)
Table 36. Global Nucleic Acid Based Gene Therapy Sales by Region (2019-2025) & (K MT)
Table 37. Global Nucleic Acid Based Gene Therapy Sales Market Share by Region (2019-2025)
Table 38. North America Nucleic Acid Based Gene Therapy Sales by Country (2019-2025) & (K MT)
Table 39. Europe Nucleic Acid Based Gene Therapy Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Nucleic Acid Based Gene Therapy Sales by Region (2019-2025) & (K MT)
Table 41. South America Nucleic Acid Based Gene Therapy Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Nucleic Acid Based Gene Therapy Sales by Region (2019-2025) & (K MT)
Table 43. Global Nucleic Acid Based Gene Therapy Production (K MT) by Region (2019-2025)
Table 44. Global Nucleic Acid Based Gene Therapy Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Region (2019-2025)
Table 46. Global Nucleic Acid Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Nucleic Acid Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Nucleic Acid Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Nucleic Acid Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Nucleic Acid Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Wave Life Sciences Nucleic Acid Based Gene Therapy Basic Information
Table 52. Wave Life Sciences Nucleic Acid Based Gene Therapy Product Overview
Table 53. Wave Life Sciences Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Wave Life Sciences Business Overview
Table 55. Wave Life Sciences Nucleic Acid Based Gene Therapy SWOT Analysis
Table 56. Wave Life Sciences Recent Developments
Table 57. Imugene Nucleic Acid Based Gene Therapy Basic Information
Table 58. Imugene Nucleic Acid Based Gene Therapy Product Overview
Table 59. Imugene Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Imugene Business Overview
Table 61. Imugene Nucleic Acid Based Gene Therapy SWOT Analysis
Table 62. Imugene Recent Developments
Table 63. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Basic Information
Table 64. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Overview
Table 65. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Sarepta Therapeutics Nucleic Acid Based Gene Therapy SWOT Analysis
Table 67. Sarepta Therapeutics Business Overview
Table 68. Sarepta Therapeutics Recent Developments
Table 69. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Basic Information
Table 70. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
Table 71. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Alnylam Pharmaceuticals Business Overview
Table 73. Alnylam Pharmaceuticals Recent Developments
Table 74. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Basic Information
Table 75. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
Table 76. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Ionis Pharmaceuticals Business Overview
Table 78. Ionis Pharmaceuticals Recent Developments
Table 79. Moderna Nucleic Acid Based Gene Therapy Basic Information
Table 80. Moderna Nucleic Acid Based Gene Therapy Product Overview
Table 81. Moderna Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Moderna Business Overview
Table 83. Moderna Recent Developments
Table 84. BioNTech Nucleic Acid Based Gene Therapy Basic Information
Table 85. BioNTech Nucleic Acid Based Gene Therapy Product Overview
Table 86. BioNTech Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. BioNTech Business Overview
Table 88. BioNTech Recent Developments
Table 89. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Basic Information
Table 90. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Overview
Table 91. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Nutcracker Therapeutics Business Overview
Table 93. Nutcracker Therapeutics Recent Developments
Table 94. Deep Genomics Nucleic Acid Based Gene Therapy Basic Information
Table 95. Deep Genomics Nucleic Acid Based Gene Therapy Product Overview
Table 96. Deep Genomics Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Deep Genomics Business Overview
Table 98. Deep Genomics Recent Developments
Table 99. Sirnaomics Nucleic Acid Based Gene Therapy Basic Information
Table 100. Sirnaomics Nucleic Acid Based Gene Therapy Product Overview
Table 101. Sirnaomics Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Sirnaomics Business Overview
Table 103. Sirnaomics Recent Developments
Table 104. Laronde Nucleic Acid Based Gene Therapy Basic Information
Table 105. Laronde Nucleic Acid Based Gene Therapy Product Overview
Table 106. Laronde Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Laronde Business Overview
Table 108. Laronde Recent Developments
Table 109. Abogen Biosciences Nucleic Acid Based Gene Therapy Basic Information
Table 110. Abogen Biosciences Nucleic Acid Based Gene Therapy Product Overview
Table 111. Abogen Biosciences Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Abogen Biosciences Business Overview
Table 113. Abogen Biosciences Recent Developments
Table 114. Global Nucleic Acid Based Gene Therapy Sales Forecast by Region (2025-2032) & (K MT)
Table 115. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Nucleic Acid Based Gene Therapy Sales Forecast by Country (2025-2032) & (K MT)
Table 117. North America Nucleic Acid Based Gene Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Nucleic Acid Based Gene Therapy Sales Forecast by Country (2025-2032) & (K MT)
Table 119. Europe Nucleic Acid Based Gene Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Nucleic Acid Based Gene Therapy Sales Forecast by Region (2025-2032) & (K MT)
Table 121. Asia Pacific Nucleic Acid Based Gene Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Nucleic Acid Based Gene Therapy Sales Forecast by Country (2025-2032) & (K MT)
Table 123. South America Nucleic Acid Based Gene Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Nucleic Acid Based Gene Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Nucleic Acid Based Gene Therapy Sales Forecast by Type (2025-2032) & (K MT)
Table 127. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Nucleic Acid Based Gene Therapy Price Forecast by Type (2025-2032) & (USD/MT)
Table 129. Global Nucleic Acid Based Gene Therapy Sales (K MT) Forecast by Application (2025-2032)
Table 130. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Nucleic Acid Based Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nucleic Acid Based Gene Therapy Market Size (M USD), 2019-2032
Figure 5. Global Nucleic Acid Based Gene Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Nucleic Acid Based Gene Therapy Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nucleic Acid Based Gene Therapy Market Size by Country (M USD)
Figure 11. Nucleic Acid Based Gene Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Nucleic Acid Based Gene Therapy Revenue Share by Manufacturers in 2023
Figure 13. Nucleic Acid Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nucleic Acid Based Gene Therapy Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nucleic Acid Based Gene Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nucleic Acid Based Gene Therapy Market Share by Type
Figure 18. Sales Market Share of Nucleic Acid Based Gene Therapy by Type (2019-2025)
Figure 19. Sales Market Share of Nucleic Acid Based Gene Therapy by Type in 2023
Figure 20. Market Size Share of Nucleic Acid Based Gene Therapy by Type (2019-2025)
Figure 21. Market Size Market Share of Nucleic Acid Based Gene Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nucleic Acid Based Gene Therapy Market Share by Application
Figure 24. Global Nucleic Acid Based Gene Therapy Sales Market Share by Application (2019-2025)
Figure 25. Global Nucleic Acid Based Gene Therapy Sales Market Share by Application in 2023
Figure 26. Global Nucleic Acid Based Gene Therapy Market Share by Application (2019-2025)
Figure 27. Global Nucleic Acid Based Gene Therapy Market Share by Application in 2023
Figure 28. Global Nucleic Acid Based Gene Therapy Sales Growth Rate by Application (2019-2025)
Figure 29. Global Nucleic Acid Based Gene Therapy Sales Market Share by Region (2019-2025)
Figure 30. North America Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Nucleic Acid Based Gene Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Nucleic Acid Based Gene Therapy Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Nucleic Acid Based Gene Therapy Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Nucleic Acid Based Gene Therapy Sales Market Share by Country in 2023
Figure 37. Germany Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Nucleic Acid Based Gene Therapy Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Nucleic Acid Based Gene Therapy Sales Market Share by Region in 2023
Figure 44. China Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Nucleic Acid Based Gene Therapy Sales and Growth Rate (K MT)
Figure 50. South America Nucleic Acid Based Gene Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Nucleic Acid Based Gene Therapy Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Nucleic Acid Based Gene Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Nucleic Acid Based Gene Therapy Production Market Share by Region (2019-2025)
Figure 62. North America Nucleic Acid Based Gene Therapy Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Nucleic Acid Based Gene Therapy Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Nucleic Acid Based Gene Therapy Production (K MT) Growth Rate (2019-2025)
Figure 65. China Nucleic Acid Based Gene Therapy Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Nucleic Acid Based Gene Therapy Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Nucleic Acid Based Gene Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Nucleic Acid Based Gene Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Nucleic Acid Based Gene Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Nucleic Acid Based Gene Therapy Market Share Forecast by Application (2025-2032)
